BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32591439)

  • 1. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
    Kurella Tamura M; Gaussoin SA; Pajewski NM; Chelune GJ; Freedman BI; Gure TR; Haley WE; Killeen AA; Oparil S; Rapp SR; Rifkin DE; Supiano M; Williamson JD; Weiner DE;
    J Am Soc Nephrol; 2020 Sep; 31(9):2122-2132. PubMed ID: 32591439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Pressure, Incident Cognitive Impairment, and Severity of CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Babroudi S; Tighiouart H; Schrauben SJ; Cohen JB; Fischer MJ; Rahman M; Hsu CY; Sozio SM; Weir M; Sarnak M; Yaffe K; Tamura MK; Drew D;
    Am J Kidney Dis; 2023 Oct; 82(4):443-453.e1. PubMed ID: 37245689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
    Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
    ; Williamson JD; Pajewski NM; Auchus AP; Bryan RN; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Erus G; Fine LJ; Gaussoin SA; Harris D; Hsieh MK; Johnson KC; Kimmel PL; Tamura MK; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nasrallah IM; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB
    JAMA; 2019 Feb; 321(6):553-561. PubMed ID: 30688979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Intensive vs Standard Blood Pressure Reduction and Association With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis.
    Dallaire-Théroux C; Quesnel-Olivo MH; Brochu K; Bergeron F; O'Connor S; Turgeon AF; Laforce RJ; Verreault S; Camden MC; Duchesne S
    JAMA Netw Open; 2021 Nov; 4(11):e2134553. PubMed ID: 34807261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Pajewski NM; Berlowitz DR; Bress AP; Callahan KE; Cheung AK; Fine LJ; Gaussoin SA; Johnson KC; King J; Kitzman DW; Kostis JB; Lerner AJ; Lewis CE; Oparil S; Rahman M; Reboussin DM; Rocco MV; Snyder JK; Still C; Supiano MA; Wadley VG; Whelton PK; Wright JT; Williamson JD
    J Am Geriatr Soc; 2020 Mar; 68(3):496-504. PubMed ID: 31840813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
    Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
    JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of urine albumin to creatinine attenuates the association of dementia with hip fracture risk.
    Bůžková P; Barzilay JI; Fink HA; Robbins JA; Cauley JA; Fitzpatrick AL
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4116-23. PubMed ID: 25148233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants.
    Nadkarni GN; Chauhan K; Rao V; Ix JH; Shlipak MG; Parikh CR; Coca SG
    Am J Kidney Dis; 2019 Jan; 73(1):31-38. PubMed ID: 30291011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
    Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
    Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study.
    Gaussoin SA; Pajewski NM; Chelune G; Cleveland ML; Crowe MG; Launer LJ; Lerner AJ; Martindale-Adams J; Nichols LO; Ogrocki PK; Sachs BC; Sink KM; Supiano MA; Wadley VG; Wilson VM; Wright CB; Williamson JD; Reboussin DM; Rapp SR
    J Am Geriatr Soc; 2022 May; 70(5):1384-1393. PubMed ID: 34826341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
    Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
    Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
    Kurella Tamura M; Gaussoin S; Pajewski NM; Zaharchuk G; Freedman BI; Rapp SR; Auchus AP; Haley WE; Oparil S; Kendrick J; Roumie CL; Beddhu S; Cheung AK; Williamson JD; Detre JA; Dolui S; Bryan RN; Nasrallah IM;
    Am J Kidney Dis; 2022 May; 79(5):677-687.e1. PubMed ID: 34543687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.
    Marcum ZA; Cohen JB; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Williamson J; Pajewski NM; Bress AP;
    JAMA Netw Open; 2022 Jan; 5(1):e2145319. PubMed ID: 35089354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKD Biomarkers, Cognitive Impairment, and Incident Dementia in an Older Healthy Cohort.
    Murray AM; Thao LTP; Ryan J; Wolfe R; Wetmore JB; Woods RL; Polkinghorne KR
    Kidney360; 2022 Mar; 3(3):435-445. PubMed ID: 35582189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
    Weiner DE; Gaussoin SA; Nord J; Auchus AP; Chelune GJ; Chonchol M; Coker L; Haley WE; Killeen AA; Kimmel PL; Lerner AJ; Oparil S; Saklayen MG; Slinin YM; Wright CB; Williamson JD; Kurella Tamura M;
    Am J Kidney Dis; 2017 Sep; 70(3):357-367. PubMed ID: 28606731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure targets for prevention of cognitive decline in patients with diabetes and hypertension: Design of the Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study.
    BPROAD Study Group
    J Diabetes; 2023 Dec; 15(12):1041-1047. PubMed ID: 37737064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
    Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK;
    Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study.
    Haring B; Wu C; Coker LH; Seth A; Snetselaar L; Manson JE; Rossouw JE; Wassertheil-Smoller S
    Am J Hypertens; 2016 Feb; 29(2):202-16. PubMed ID: 26137952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.